Login to Your Account


DUBLIN – Bavarian Nordic A/S picked up a second bulk supply order for its Imvamune smallpox vaccine from the U.S. government, a $100 million deal that comes on top of the $133 million contract it secured last year.

LONDON – A government-mandated study of how to accelerate access to new drugs will recommend that a select group of highly innovative products be singled out for special treatment, with plans agreed during development to take them all the way through regulatory approval, health technology assessment and commissioning at scale in the U.K.'s single payer NHS.

PARIS – The long-awaited reform that would untangle red tape and speed up market access in the U.K. for innovative medications and medical devices hit a roadblock called Brexit, a British exit from the European Union (EU).

More EUROPE Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: